Microviable Therapeutics

About:

Microviable Therapeutics develops microbiota ecosystem products and microbiome therapies to improve human health.

Website: http://www.microviable.com

Twitter/X: microviable

Top Investors: Immunomet Intolerance and Dysbiosis

Description:

Microviable Therapeutics is working to improve human health by creating an entire microbiota ecosystem and microbiome therapeutics. They develop novel biological drugs and personalized therapies. It is a preclinical stage exploring innovative biological therapeutics for infectious disorders based on commensal microorganisms.

Total Funding Amount:

1.5M EUR

Headquarters Location:

Gijón, Asturias, Spain

Founded Date:

2016-01-01

Contact Email:

info(AT)microviable.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-04-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai